Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection

Ipilimumab, in combination with nivolumab, is one of the promising drugs that enhance the anti-tumor immune response of patients with advanced melanoma. Since the co-administration of nivolumab with ipilimumab in the neoadjuvant setting expands melanoma-reactive T cells at the primary site of melano...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Med (Lausanne)
Glavni autori: Fujimura, Taku, Kambayashi, Yumi, Sato, Yota, Tanita, Kayo, Amagai, Ryo, Hashimoto, Akira, Hidaka, Takanori, Aiba, Setsuya
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Medicine
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607934/
https://ncbi.nlm.nih.gov/pubmed/31297373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00140
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items